SCOPUS 정보 검색 플랫폼

Seminars in Oncology

Volumn 27, Issue 6 SUPPL. 12, 2000, Pages 86-90

High-dose rituximab therapy in chronic lymphocytic leukemia

(2) Keating, M a O'Brien, S a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; B CELL LYMPHOMA; B LYMPHOCYTE; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONFERENCE PAPER; DOSE RESPONSE; DRUG ACTIVITY; DRUG APPROVAL; DRUG MEGADOSE; FOOD AND DRUG ADMINISTRATION; HUMAN; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; RELAPSE;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC; MALE; RECURRENCE;

EID: 0034468409 PISSN: 00937754 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (45)

References (13)

1
- 0034160344
- Morphological and immunophenotypic features of chronic lymphocytic leukemia
- Foa R, Hoffbrand AV (eds): Reviews in Clinical and Experimental Hematology (vol 4). Oxford, UK, Blackwell Science
- (2000) , pp. 22-47
- Matutes, E.¹ Polliack, A.²

2
- 0028149568
- The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
- (1994) Leukemia , vol.8 , pp. 1640-1645
- Matutes, E.¹ Owusu-Ankomah, K.² Morilla, R.³

3
- 0003258510
- Fludarabine (FAMP) and mitoxantrone therapy in chronic lymphocytic leukemia (CLL)
- abstr
- (1996) Proc Am Soc Hematol , vol.88
- O'Brien, S.¹ Kantarjian, M.² Beran, M.³

4
- 0035282055
- Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
- in press
- J Clin Oncol
- O'Brien, S.M.¹ Kantarjian, H.M.² Cortes, J.³

5
- 0001263897
- CD20 Workshop panel report
- Schlossman SF, Boumsell L, Gilks W, et al (eds): Leucocyte Typing V. White Cell Differentiation Antigens. Oxford, UK, Oxford University Press
- (1995) , pp. 511-514
- Zhou, L.J.¹ Tedder, T.F.²

6
- 17144455839
- IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
- (1997) J Clin Oncol , vol.15 , pp. 3266-3274
- Maloney, D.G.¹ Grillo-López, A.J.² Bodkin, D.J.³

7
- 0033968522
- European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma
- (2000) J Clin Oncol , vol.18 , pp. 317-324
- Foran, J.M.¹ Rohatiner, A.Z.² Cunningham, D.³

8
- 0345337254
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
- (1998) J Clin Oncol , vol.16 , pp. 2825-2833
- McLaughlin, P.¹ Grillo-López, A.² Link, B.K.³

9
- 0026655066
- Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia
- (1992) Am J Hematol , vol.40 , pp. 259-263
- Almasri, N.M.¹ Duque, R.E.² Iturraspe, J.³

10
- 0000419543
- Phase I/II study of thrice weekly rituximab in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): A feasible and active regimen
- abstr
- (1999) Blood , vol.94
- Byrd, J.C.¹ Grever, M.R.² Davis, B.³

11
- 0031837813
- Levels of expression of CD19 and CD20 in chronic B cell leukaemias
- (1998) J Clin Pathol , vol.51 , pp. 364-369
- Ginaldi, L.¹ De Martinis, M.² Matutes, E.³

12
- 0006991616
- Fludarabine and cyclophosphamide combined with Rituxan (FCR) is a potent cytoreductive regimen as initial therapy of chronic lymphocytic leukemia
- abstr 21
- (2000) Proc Am Soc Clin Oncol , vol.19
- Keating, M.J.¹ O'Brien, S.² Cortes, J.³

13
- 0005840397
- Rituximab induced apoptosis in DHL-4 cells: Effect of IL-4 and GM-CSF
- abstr
- (1999) Proc Am Soc Hematol , vol.94 , pp. 254
- Sivaraman, S.¹ Deshpande, C.G.² Kunkel, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.